baber/WOPTO huggingface dataset:
Patent EP-0654055-B1 (EP)
Inventor: PATZSCHKE HANS-PETER
IPC: C08G18/62
Filed: 1993-08-09
Granted: 1997-12-03
Abstract: A water-dilutable coating agent, its preparation and use are disclosed. The coating agent contains A) 40 to 95 % by weight of at least one OH group-containing binder as an aqueous dispersion of a polymer resin or of a mixture of polymer resins on the basis of olefinically unsaturated compounds. The polymer resin or said mixture have in average a hydroxyl number from 10 to 300, a numeric average of the molar mass (Mn) from 500 to 200 000 and a content of acid functionalities lower than 80 mEqu and/or a content of ethylene oxide units lower than 150 mEqu, with respect to 100 g solid resin. When acid functionalities and ethylene oxide units are both available, the sum of the acid functionalities and of the ethylene oxide units is comprised between 1 and 200 mEqu, and the acid functionalities are if required at least partially neutralised. The coating agent also contains B) 60 to 5 % by weight of one or several polyisocyanates with more than one free isocyanate group which are liquid at room temperature, if required after admixture of one or several organic solvents, the percentages by weight of A) and B) relating to the content of solid resin and adding up to 100 % by weight, and C) if required one or several additional binders, usual pigments, fillers and/or lacquer-usual additives and auxiliary substances.
Patent EP-0686009-B1 (EP)
Inventor: BENYAMINE MONIQUE
IPC: A47B9/04
Filed: 1994-02-25
Granted: 1996-10-09
Abstract: A work table, particularly for the disabled, including a tiltable table top mounted on an underframe consisting of a gantry-like frame with at least two vertically adjustable legs (12, 14) supporting the table top (10), and a cross member (16) joining the legs. The table top (10) has at least one armrest (74, 76) on its front longitudinal edge. Said table further comprises at least one fixture mounting member (46, 48) coupled to the underframe and extending over the table top (10).
Patent EP-0640051-B1 (EP)
Inventor: BURGOYNE KEVIN
IPC: B62L3/02
Filed: 1994-03-18
Granted: 1998-12-09
Abstract: An operating lever mechanism for a master cylinder which includes a mounting bracket (12) and a lever (23) mounted on the bracket through a pivot pin (22). The lever is connected to a master cylinder actuating rod (25) and the pivot pin (22) is adjustably mounted on the bracket in slots (27) so that by turning an adjuster wheel (31) the operating lever ratio of the mechanism can be adusted as desired.
Patent EP-0648144-B1 (EP)
Inventor: HOEHLE GLENN
IPC: B01D29/33
Filed: 1994-04-12
Granted: 1997-09-10
Abstract: PCT No. PCT/CH94/00073 Sec. 371 Date Dec. 19, 1994 Sec. 102(e) Date Dec. 19, 1994 PCT Filed Apr. 12, 1994 PCT Pub. No. WO94/23819 PCT Pub. Date Oct. 27, 1994.A filter for sterile filtration of suspensions, comprising a pressure vessel, at least one candle filter element arranged in the pressure vessel, the at least one filter element having a hollow member with a lower portion which is formed as a filtering medium and an upper portion which is formed as a closed tube with an unwrapped self-supporting filtering medium, and a tube for carrying off a filtrate, the tube being formed as a central tube which is arranged in the hollow member and the filtering medium and is removable so as to permit inspection and cleaning of the filter element without opening the pressure vessel.
Patent EP-0706679-B1 (EP)
Inventor: CAMPBELL JAMES STANLEY
IPC: G03G9/09
Filed: 1994-03-29
Granted: 1997-09-17
Abstract: Coloured cyan toner for electroreprography and laser printing based on Solvent Blue 70, and a trichomatic set of coloured toners based on Solvent Blue 70, benzodifuranone red dyes and azo pyridone yellow dyes.
Patent EP-0643783-B1 (EP)
Inventor: TINCMAN HALUK
IPC: D06P5/12
Filed: 1994-03-30
Granted: 1998-07-01
Abstract: A differential printing process for textiles, in particular carpets, made of polyamide fibres of various dyeability, is characterized in that a cationic resist based on quaternary fatty amine polyglycol ethers or on quaternary ammonium polyglycols is added to the usual printing paste for polyamide fibres. The printing paste may also contain several different dyestuff types, as in the differential dyeing process, and may if required be continuously cross-dyed in a manner known per se in a single operation by a wet-on-wet differential dyeing process. To carry out this process, a usual printing paste for polyamide fibres is used which is characterized in that it contains a cationic resist based on quaternary fatty amine polyglycol ethers or quaternary ammonium polyglycols.
Patent EP-0712398-B1 (EP)
Inventor: MACKENZIE ALEXANDRA RODERICK
IPC: C07D405/12
Filed: 1994-07-18
Granted: 1997-05-07
Abstract: A compound of the formula: or a pharmaceutically acceptable salt thereof, wherein X, O R, R1, R2, R3, and R4 are defined in the specification; compositions containing such compounds; intermediates used in the preparation of such compounds; and methods for treating a disease associated with the altered tone and/or motility of smooth muscle, for example chronic obstructive airways disease, asthma, urinary incontinence, irritable bowel syndrome, diverticular disease, oesophageal achalasia, and hypertension.
Patent EP-0669912-B1 (EP)
Inventor: OHKUBO MITSURU
IPC: C07D211/60
Filed: 1994-09-21
Granted: 2001-12-05
Abstract: This invention relates to  beta -alanine derivatives represented by the following formula : <CHEM> wherein each symbol is as defined in the specification and pharmaceutically acceptable salt thereof which is glycoprotein IIb/IIIa antagonist, inhibitor of blood platelets aggregation and inhibitor of the binding of fibrinogen to blood platelets, to processes for the preparation thereof, to a pharmaceutical composition comprising the same and to a method for the prevention and/or treatment diseases indicated in the specification to a human being or an animal.
Patent EP-0720544-B1 (EP)
Inventor: MARQUARDT JAKOB
IPC: G07C9/00
Filed: 1994-09-30
Granted: 1997-03-05
Abstract: Un système électronique (1) de verrouillage des portes d'un véhicule à moteur comprend une clé (2) qui contient des éléments électroniques (14) appropriés et un récepteur situé sur le véhicule à moteur. La clé (2) échange avec le récepteur un signal codé d'actionnement (7, 8). Des éléments de décodage du signal codé d'actionnement (7, 8) actionnent un appareil de commande (20), lorsque l'évaluation du signal d'actionnement (7, 8) a un résultat positif, afin de modifier l'état de verrouillage des portes (12) de la voiture, en les verrouillant ou en les déverrouillant. Au moins un dispositif de traitement de signaux (6) qui contient le récepteur est monté dans une porte (12) de la voiture. Ce dispositif de traitement de signaux (6) comprend des éléments inductifs, optiques ou similaires de transmission sans contact d'énergie à la clé (2). La transmission d'énergie est déclenchée lorsque la clé (2) se rapproche de la porte correspondante (12) de la voiture. Les éléments électroniques (14) de la clé (2) sont activés lorsqu'ils reçoivent l'énergie transmise et sont ainsi mis en état de remplir leur fonction.
Patent EP-0723554-B1 (EP)
Inventor: GHADIRI REZA M
IPC: C07K7/64
Filed: 1994-10-14
Granted: 2003-09-24
Abstract: Cyclic homodetic peptides having a repeating D-L-chirality motif are shown to have a stable disk conformation with the amino acid side chains extending radially outward and the carbonyl and amino groups extending axially upward or downward. Such cyclic peptides can be employed as subunits in the assembly of molecular tubes. Cyclic peptides having a repeating D-L-chirality motif and lacking mutually repulsive side-chains are shown to stack atop one another in an anti-parallel fashion and are shown to be held together by the formation of beta-sheet hydrogen bonding. The stacked cyclic peptides form a molecular tube having a central channel. The diameter of the channel is determined by the size cyclic peptide. If the cyclic peptide includes ionizable amino acid residues, e.g. glutamic acid or lysine, assembly and disassembly of the molecular tubes can be controlled by varying the pH. If the cyclic peptide includes hydrophobic amino acid residues, the molecular tube will insert into a lipid membrane. In such instances, the molecular tube provides a transmembrane channel. The channel can be gated or ungated. Molecular tubes can be terminated with a terminal cyclic peptide having methylated amino groups in one orientation. Molecular tubes may be employed as drug carriers, molecular sieves, reaction vessels, membrane channels, and other uses.
Patent EP-0715022-B1 (EP)
Inventor: DAHL JOHANNES DIPL-ING
IPC: E01B29/00
Filed: 1995-03-30
Granted: 1999-09-22
Abstract: A process cycle is arranged for a number of fixing frames with rail support point elements connected at pregiven positions. The process cycle has a receiving station with receiving units and in the process direction, and with it in the track direction, leads to a positioning station with adjusting units. The individual fixing frames or fixing frame groups are moved from the receiving station to the positioning station and accurately positioned there, after which fixing frame after fixing frame is temporarily fastened to the concrete track with a space in between and is freed from the adjusting unit.
Patent EP-0698348-B1 (EP)
Inventor: MAEYRAE-MAEKINEN ANNIKA
IPC: A23L3/3571
Filed: 1995-03-15
Granted: 2000-01-12
Abstract: The invention relates to inhibition of clostridia with lactic acid bacteria. In particular, the invention relates to the use of Lactobacillus rhamnosus in the food industry to inhibit the growth and activity of clostridia. Preferred embodiments of the invention include the use of Lactobacillus rhamnosus in prevention of butyric acid fermentation and in cheese production.
Patent EP-0721878-B1 (EP)
Inventor: ZEHNDER JUERG
IPC: B62D27/06
Filed: 1995-12-21
Granted: 2000-03-15
Abstract: The part consists of a structure of connected groups, with connection profiles having parallel longitudinal profile axis. The profiles (50,52) have formed first longitudinal strips (56) or first grooves (54). These engage or lock with each other, so that the profiles are positively locked together. This permits the profiles to be connected positively via rivet, screw, or clamp connections. The engaging profiles are connected via an outer batten (58), which extends in the longitudinal profile axis. The batten has two parallel longitudinal grooves (60), which engage with strips (62) formed on each profile. The batten is fixed positively to the profiles via tensile-loaded screws (66).
Patent EP-0787372-B1 (EP)
Inventor: WAAS CHARLES W
IPC: H01R4/24
Filed: 1994-10-21
Granted: 2002-09-18
Abstract: A protected terminal block has a housing (10) having a plurality of test ports (18) and a plurality of electrical contact elements (40), each of which includes a test lead (48) which is accessible through a test port (18). The electrical contact elements are configured in the housing and connected to an exchange wire which is secured to a stub cable. A protection module retainer (140) is secured to a side of the housing (10) proximate the test ports (18) to form a plurality of retaining cups (142) adapted to receive a protection module (100). A grounding strip (150) is secured to ground and retained between the protection module retainer (140) and the housing (10) proximate the test ports (18), the grounding strip (150) having a plurality of integral ground connectors (158). A protection module (100) is provided having a protector (116) which is connected to a pair of terminal block contact elements (102) and a ground connector (160). When inserted into a retaining cup (142), the terminal block contact elements (102) engage a pair of corresponding test leads (48) in test ports and the protection module ground connector (160) engages the grounding strip ground connector (158) to provide surge protection to a pair of conductive paths through the connection of the test leads in the test ports. The protection module may be removed or replaced as needed.
Patent EP-0716842-B1 (EP)
Inventor: YAMAKI RUMI
IPC: A61F5/44
Filed: 1995-04-07
Granted: 2002-07-10
Abstract: A disposable body fluid absorbing habiliments (1) comprises leakage preventive banks (10) of a soft and elastic material provided on inner surfaces on right and left sides of a crotch contact area (9). Top surfaces (12) of the leakage preventive banks (10) are composed of convex portions (13) and concave portions (14) which extend in right and left directions and arranged alternately in a longitudinal direction.
Patent EP-0780009-B1 (EP)
Inventor: MYERS WILLIAM LORING
IPC: G06T15/10
Filed: 1995-09-08
Granted: 2001-03-28
Abstract: The virtual reality imaging system takes a multidimensional space that contains real world objects and phenomena, be they static or dynamic in nature, and enables a user to define a point and/or a path through this multidimensional space. The apparatus then displays the view to the user that would be seen from the point and/or path through the multidimensional space. This view is filtered through user definable characteristics that refine the real world phenomena and objects to a perspective that is of interest to the user. This filtered view presents the user with a virtual view of the reality contained within this multidimensional space, which virtual reality presents data to the user of only objects, views and phenomena that are of particular interest to the user.
Patent EP-0869850-B1 (EP)
Inventor: THALER BARRY J
IPC: C04B38/06
Filed: 1995-11-09
Granted: 2002-09-25
Abstract: The present invention provides a method of forming a fluidtight electrical conduit through a high aspect ratio hole, the method comprising sintering a via ink to form the electrical conduit and to seal the hole.
Patent EP-0802909-B1 (EP)
Inventor: PEET NORTON P
IPC: A61K31/42
Filed: 1995-12-15
Granted: 2001-10-04
Abstract: This invention relates to oxazolidine inhibitors of calpain and/or cathepsin B and to compositions containing them. As inhibitors of calpain and/or cathepsin B, the compounds are useful in the treatment of patients afflicted with acute or chronic neurodegenerative disorders.
Patent EP-0727265-B1 (EP)
Inventor: WITTE FRITZ
IPC: B21F45/16
Filed: 1996-02-03
Granted: 2000-05-10
Abstract: The conveyor moves a length of connectors away from a connector forming device, which forms the connectors into a C- shape. The conveyor units incorporate correction members (22), which act forming on the connectors after the first forming process. The correction members incorporate stretcher elements (23), which act on the connectors in axial direction. The stretchers incorporate two toothed gears (26,27), and the tooth meshing positions of the gears into the connectors, are relatively adjustable. The front gear is turnable on its shaft (28) relative to the rear gear, into stretching position.
Patent EP-0750981-B1 (EP)
Inventor: WALKER CRAIG WILLIAM
IPC: B29D11/00
Filed: 1996-04-30
Granted: 2001-06-20
Abstract: An automated demolding apparatus for mechanically separating contact lens mold portions of a mold assembly. The mold assembly includes a first front mold portion having a central mold section with a surrounding flange, and a corresponding second back mold portion also having a central mold section with a surrounding flange, with a molded contact lens being formed between the front and back mold portions. The demolding apparatus includes restraining fingers positioned between and on opposite sides of the spaced flanges of the first and second mold portions and against the flange of the first mold portion. A separating fixture includes separating fingers positioned between and on opposite sides of the spaced flanges of the first and second mold portions and against the flange of the second mold portion. Before demolding, the second mold portion is irradiated by a laser beam, which is absorbed thereby to cause a substantial temperature gradient between the second mold portion and the contact lens being demolded. The temperature gradient causes a differential expansion and shifting of the surface of the heated second mold portion relative to the surface of the lens to lessen the adhesion therebetween to assist in separation of the mold portions, while leaving the lens in the first mold portion. During demolding, the separating fixture is subjected to a substantially vertical prying motion relative to the restraining fingers to separate the second mold portion from the first mold portion.
Patent EP-0779075-B1 (EP)
Inventor: PHILIBERT DANIEL
IPC: A61K31/565
Filed: 1996-12-12
Granted: 2001-10-31
Abstract: Use of 3 alpha -Hydroxy-5 alpha -androsta-16-ene of formula (I) and its esters as medicaments.
Patent EP-0820373-B1 (EP)
Inventor: JUST BERNHARD
IPC: B29C45/14
Filed: 1996-03-23
Granted: 1999-07-21
Abstract: Es wird eine Anordnung aus zwei miteinander zu verbindenden Teilen aus thermoplastischem Material vorgeschlagen. Beispielsweise ist in einem dichten Gehäuse (8) eine ringförmige Spule (7) angeordnet, wobei das Gehäuse (8) und der Spulenkörper (1) aus dem thermoplastischen Material mit unterschiedlichem Schmelzpunkt bestehen und beide über Nuten miteinander verzahnt sind. Das Gehäuse (8) ummantelt an mindestens einer Seite, an der ein Spulenschild (3) als Fortsatz angeordnet ist, dieses nahezu vollständig. Das Spulenschild (3) weist hier auf der äußeren Stirnseite (4) und außen auf dem Umfang des Spulenschildes (3) Ringnuten (5, 6) auf, in die das thermoplastische Material des Gehäuses (8) während der Ummantelung aushärtend einbringbar ist.
Patent EP-0834183-B1 (EP)
Inventor: REISS HEIKO
IPC: H01H50/14
Filed: 1996-06-12
Granted: 1998-12-16
Abstract: PCT No. PCT/DE96/01033 Sec. 371 Date Nov. 6, 1997 Sec. 102(e) Date Nov. 6, 1997 PCT Filed Jun. 12, 1996 PCT Pub. No. WO97/01182 PCT Pub. Date Jan. 9, 1997The relay has a magnetic system with a coil (2), a core (4), a yoke (5) and also an armature (6) mounted on the yoke. A contact spring (7) is fastened to the armature and the end section of said spring interacts with one or more mating contact elements. The contact spring (7) and/or each mating contact element (21, 22, 25, 26) are connected to connection elements which are all anchored in a common plane in separate pockets (33, 34, 35) of an insulating wall (32) on that side of the coil which is opposite the second yoke limb.
Patent EP-0850249-B1 (EP)
Inventor: MORGAN UNA
IPC: C12Q1/68
Filed: 1996-06-25
Granted: 2005-08-03
Abstract: PCT No. PCT/AU96/00387 Sec. 371 Date Mar. 20, 1998 Sec. 102(e) Date Mar. 20, 1998 PCT Filed Jun. 25, 1996 PCT Pub. No. WO97/02281 PCT Pub. Date Jan. 23, 1997The invention provides a purified and isolated Cryptosporidium DNA sequence comprising the nucleotide sequence: GATGGTACTGGATAGATAGTGGAAGTCCCGTATCAGTTCGAGATTCTGAAATTA ATTGGACATCAAGTTATAAAGCAAGCTGGTTATTAAGATTCAAATTTCCCTTTGA AAAGTGTGGCTTTTTTGATATTGGAGGGTTAGGAAGAAGGTT plus methods and kits for detecting and/or identifying the presence of Cryptosporidium.
Patent EP-0828596-B1 (EP)
Inventor: MURSCHALL URSULA
IPC: B29C48/90
Filed: 1996-05-21
Granted: 1999-09-01
Abstract: The invention relates to a transparent, amorphous sheet having a thickness in the range from 1 to 20 mm which contains, as principal constituent, a crystallizable thermoplastic, where the surface gloss, measured in accordance with DIN 67530 (measurement angle 20°), is greater than 130, the light transmission, measured in accordance with ASTM D 1003, is greater than 84%, and the haze of the sheet, measured in accordance with ASTM D 1003, is less than 15%, to a process for the production of the sheet, and to the use of the sheet.
Patent EP-0854703-B1 (EP)
Inventor: CAUWET-MARTIN DANIELE
IPC: A61K8/00
Filed: 1996-09-16
Granted: 2002-01-02
Abstract: The present invention relates to a cosmetic or dermatological composition for treating keratin substances, in particular human hair, comprising a grafted silicone polymer with a non-silicone organic skeleton with at least one monomer containing at least one polysiloxane and at least one crosslinked or non-crosslinked thickening polymer or copolymer of methacrylamide or a methacrylamide derivative.
Patent EP-0797765-B1 (EP)
Inventor: KUBO YASUHIRO
IPC: A61B5/00
Filed: 1996-10-02
Granted: 2007-02-21
Abstract: The present invention relates to a method for spectrometrically measuring an isotopic gas comprising the steps of introducing a gaseous test sample containing a plurality of component gases including  12 CO 2  and  13 CO 2  into a cell, measuring intensity of light transmitted through the gaseous test sample at wavelengths suitable for the respective component gases, and processing data of the light intensity to determine concentrations of the component gases in the gaseous test sample, the method comprising a first step of introducing the gaseous test sample into the cell and measuring absorbances of the respective component gases in the gaseous test sample; a second step of determining concentrations and concentration ratios of the component gases in the gaseous test sample on the basis of calibration curves; and a third step of obtaining concentration ratio correction values for the component gases on the basis of the concentrations of the component gases obtained in the second step by using correction curves preliminary prepared by measuring absorbances of the component gases in gaseous samples containing the respective component gases in known concentrations with known concentration ratios, determining concentrations and concentration ratios of the component gases in the gaseous samples on the basis of the calibration curves, and by plotting the thus determined concentrations and concentration ratios of the component gases in the gaseous samples, and respectively dividing the concentration ratios of the component gases obtained in the second step by the concentration ratio correction values for the component gases, thereby correcting the concentration ratios of the component gases in the gaseous test sample.
Patent EP-0881219-B1 (EP)
Inventor: MAEDA TOSHIO
IPC: A61K31/425
Filed: 1996-12-16
Granted: 2004-04-07
Abstract: The invention provides novel N-substituted dioxothiazolidylbenzamide derivatives that improve the insulin resistance and have potent hypoglycemic effect and lipid-lowering effect, and the process for preparing them, and relates to N-substituted dioxothiazolidylbenzamide derivatives characterized by being represented by a general formula (1) <CHEM> Äwherein R<1> and R<2> denote identically or differently hydrogen atoms, lower alkyl groups with carbon atoms of 1 to 4, lower alkoxy groups with carbon atoms of 1 to 3, lower haloalkyl groups with carbon atoms of 1 to 3, lower haloalkoxy groups with carbon atoms of 1 to 3, halogen atoms or hydroxyl groups, or R<1> and R<2> combine to form a methylenedioxy group, R<3> denotes a hydrogen atom, lower alkoxys group with carbon atoms of 1 to 3, hydroxyl group or halogen atom, R<4> denotes a hydrogen or lower alkyl group with carbon atoms of 1 to 3, n denotes an integer of 0 to 2, and X denotes N or CHÜ, and process for preparing the same.